{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:04Z","timestamp":1792782664482,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Maruho Co., Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To obtain current epidemiological information on primary focal hyperhidrosis in Japan, a large epidemiological survey was conducted using a web-based questionnaire. The prevalence of primary focal hyperhidrosis was 10.0% and the site-specific prevalence was highest for primary axillary hyperhidrosis (5.9%). The proportion of respondents with primary focal hyperhidrosis who had consulted a physician was 4.6%, which was similar to the low prevalence reported previously in 2013 in Japan. A questionnaire survey for physicians and individuals with primary axillary hyperhidrosis on the current medical management of primary axillary hyperhidrosis showed that physicians recognized the existence of patients who were very worried about hyperhidrosis, but failed to provide active treatment. Regarding the information provided by patients to physicians at presentation, it was found that patients failed to provide sufficient information to the physicians about their worries in daily life. Among individuals who had sought medical care with primary axillary hyperhidrosis, 62.3% reported that they were not currently receiving treatment, highlighting a challenge to be addressed regarding continued treatment. Frequently chosen options leading to willingness to receive treatment were less expensive treatment and highly effective treatment as well as feeling free to consult a physician, suggesting a desire for an improved medical environment.<\/jats:p>","DOI":"10.1007\/s00403-022-02365-9","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:02:51Z","timestamp":1656507771000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0771-3778","authenticated-orcid":false,"given":"Tomoko","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Inose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kikukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2365_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000351292","volume":"227","author":"M Augustin","year":"2013","unstructured":"Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I (2013) Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology 227:10\u201313. https:\/\/doi.org\/10.1159\/000351292","journal-title":"Dermatology"},{"key":"2365_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jaad.2016.07.001","volume":"75","author":"R Bahar","year":"2016","unstructured":"Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, Su M, Yang S, Kalia S, Zhang X, Zhou Y (2016) The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol 75:1126\u20131133. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.001","journal-title":"J Am Acad Dermatol"},{"key":"2365_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00403-016-1697-9","volume":"308","author":"J Doolittle","year":"2016","unstructured":"Doolittle J, Walker P, Mills T, Thurston J (2016) Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 308:743\u2013749. https:\/\/doi.org\/10.1007\/s00403-016-1697-9","journal-title":"Arch Dermatol Res"},{"key":"2365_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/1346-8138.12258","volume":"40","author":"T Fujimoto","year":"2013","unstructured":"Fujimoto T, Kawahara K, Yokozeki H (2013) Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol 40:886\u2013890. https:\/\/doi.org\/10.1111\/1346-8138.12258","journal-title":"J Dermatol"},{"key":"2365_CR5","first-page":"1379","volume":"125","author":"T Fujimoto","year":"2015","unstructured":"Fujimoto T, Yokozeki H, Katayama I, Kaneda M, Murota H, Tamura N (2015) Localized hyperhidrosis clinical practice guidelines, 2015 revised edition. Jpn J Dermatol 125:1379\u20131400 (in Japanese)","journal-title":"Jpn J Dermatol"},{"key":"2365_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000092285","volume":"212","author":"H Hamm","year":"2006","unstructured":"Hamm H, Naumann MK, Kowalski JW, K\u00fctt S, Kozma C, Teale C (2006) Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 212:343\u2013353. https:\/\/doi.org\/10.1159\/000092285","journal-title":"Dermatology"},{"key":"2365_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LP (2004) Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51:274\u2013286. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.029","journal-title":"J Am Acad Dermatol"},{"key":"2365_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12955-017-0693-x","volume":"15","author":"P Kamudoni","year":"2017","unstructured":"Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS (2017) The impact of hyperhidrosis on patients\u2019 daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes 15:121. https:\/\/doi.org\/10.1186\/s12955-017-0693-x","journal-title":"Health Qual Life Outcomes"},{"key":"2365_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11136-014-0825-2","volume":"24","author":"P Kamudoni","year":"2015","unstructured":"Kamudoni P, Mueller B, Salek MS (2015) The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL\u00a9). Qual Life Res 24:1017\u20131027. https:\/\/doi.org\/10.1007\/s11136-014-0825-2","journal-title":"Qual Life Res"},{"key":"2365_CR10","first-page":"707","volume":"17","author":"BM Kirsch","year":"2018","unstructured":"Kirsch BM, Burke L, Hobart J, Angulo D, Walker PS (2018) The hyperhidrosis disease severity measure-axillary: conceptualization and development of item content. J Drugs Dermatol 17:707\u2013714","journal-title":"J Drugs Dermatol"},{"key":"2365_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153719","volume":"11","author":"Y Liu","year":"2016","unstructured":"Liu Y, Bahar R, Kalia S, Huang RY, Phillips A, Su M, Yang S, Zhang X, Zhou P, Zhou Y (2016) Hyperhidrosis prevalence and demographical characteristics in dermatology outpatients in Shanghai and Vancouver. PLoS ONE 11:e0153719. https:\/\/doi.org\/10.1371\/journal.pone.0153719","journal-title":"PLoS ONE"},{"key":"2365_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s41687-019-0148-8","volume":"3","author":"LM Nelson","year":"2019","unstructured":"Nelson LM, DiBenedetti D, Pariser DM, Glaser DA, Hebert AA, Hofland H, Drew J, Ingolia D, Gillard KK, Fehnel S (2019) Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity. J Patient Rep Outcomes 3:59. https:\/\/doi.org\/10.1186\/s41687-019-0148-8","journal-title":"J Patient Rep Outcomes"},{"key":"2365_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40257-018-0395-0","volume":"20","author":"DM Pariser","year":"2019","unstructured":"Pariser DM, Hebert AA, Drew J, Quiring J, Gopalan R, Glaser DA (2019) Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: patient-reported outcomes from the ATMOS-1 and ATMOS-2 Phase III randomized controlled trials. Am J Clin Dermatol 20:135\u2013145. https:\/\/doi.org\/10.1007\/s40257-018-0395-0","journal-title":"Am J Clin Dermatol"},{"key":"2365_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1159\/000448032","volume":"232","author":"A Shayesteh","year":"2016","unstructured":"Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E (2016) Prevalence and characteristics of hyperhidrosis in Sweden: a cross-sectional study in the general population. Dermatology 232:586\u2013591. https:\/\/doi.org\/10.1159\/000448032","journal-title":"Dermatology"},{"key":"2365_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G, Committee CHA (2007) A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 33:908\u2013923. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33192.x","journal-title":"Dermatol Surg"},{"key":"2365_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51:241\u2013248. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040","journal-title":"J Am Acad Dermatol"},{"key":"2365_CR17","unstructured":"Tanizaki H, Hayashi N, Ohkawa T, Nishii K, Shimada T, The Committee of School Health, Japan Organization of Clinical Dermatologists (2020) An epidemiological study of adolescent acne using questionnaire in 2018. Jpn J Dermatol 130: 1811\u20131819 (in Japanese)"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T08:06:44Z","timestamp":1678954004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2365"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02365-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The costs of conducting the study and preparing this paper were paid for by Maruho Co., Ltd. T F received a consultant fee for medical advice for this questionnaire survey from Maruho Co., Ltd. YI, HN, and YK are employees of Maruho Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the Ethical Review Board of Kojinkai, Association of Medical Corporation Hosui General Medical Clinic. The procedures used in this study adhere to the tenets of the Declaration of Helsinki<u>.<\/u>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from subjects who confirmed the outline of the study and publishing their data on the website. Individuals aged 15\u00a0years and older were registered in the panel, and minors were enrolled in the study with their personal consent and the approval of their legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}